- Home
- DRTS vs DSM Comparison
DRTS vs DSM Comparison
Compare DRTS & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- DSM
- Stock Information
- Founded
- DRTS 2015
- DSM 1989
- Country
- DRTS Israel
- DSM United States
- Employees
- DRTS N/A
- DSM N/A
- Industry
- DRTS Medical/Dental Instruments
- DSM Investment Managers
- Sector
- DRTS Health Care
- DSM Finance
- Exchange
- DRTS Nasdaq
- DSM Nasdaq
- Market Cap
- DRTS 252.8M
- DSM 275.8M
- IPO Year
- DRTS N/A
- DSM N/A
- Fundamental
- Price
- DRTS $3.12
- DSM $5.63
- Analyst Decision
- DRTS Strong Buy
- DSM
- Analyst Count
- DRTS 2
- DSM 0
- Target Price
- DRTS $8.00
- DSM N/A
- AVG Volume (30 Days)
- DRTS 43.2K
- DSM 161.7K
- Earning Date
- DRTS 08-13-2025
- DSM 01-01-0001
- Dividend Yield
- DRTS N/A
- DSM 3.97%
- EPS Growth
- DRTS N/A
- DSM N/A
- EPS
- DRTS N/A
- DSM N/A
- Revenue
- DRTS N/A
- DSM N/A
- Revenue This Year
- DRTS N/A
- DSM N/A
- Revenue Next Year
- DRTS N/A
- DSM N/A
- P/E Ratio
- DRTS N/A
- DSM N/A
- Revenue Growth
- DRTS N/A
- DSM N/A
- 52 Week Low
- DRTS $1.93
- DSM $4.69
- 52 Week High
- DRTS $4.39
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- DRTS 59.34
- DSM 43.93
- Support Level
- DRTS $2.91
- DSM $5.56
- Resistance Level
- DRTS $3.20
- DSM $5.60
- Average True Range (ATR)
- DRTS 0.16
- DSM 0.04
- MACD
- DRTS -0.00
- DSM 0.00
- Stochastic Oscillator
- DRTS 68.70
- DSM 25.00
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.